Location History:
- Buffalo, NY (US) (2006 - 2011)
- Amherst, NY (US) (2012)
- Williamsville, NY (US) (2012)
- Richmond, VA (US) (2017 - 2019)
Company Filing History:
9 out of 310 
2 out of 403 
Years Active: 2006-2019
Title: The Innovative Contributions of Xiang-Yang Wang
Introduction
Xiang-Yang Wang is a prominent inventor based in Buffalo, NY (US), known for his significant contributions to the field of immunotherapy and vaccine formulation. With a total of 9 patents to his name, Wang has made strides in developing innovative solutions for the treatment and prevention of cancer and infectious diseases.
Latest Patents
Wang's latest patents include an immune modulator for immunotherapy and vaccine formulation. This invention features a recombinant Flagrp170 protein and pharmaceutical compositions that comprise the Flagrp170 protein and related molecules encoding the same. The Flagrp170 protein includes an NF-κB-activating domain of Flagellin and an ATP-binding domain truncated Grp170. The pharmaceutical compositions developed through this invention can be utilized for the treatment or prevention of cancer or infectious diseases.
Career Highlights
Throughout his career, Xiang-Yang Wang has worked with notable organizations such as Health Research, Inc. and Virginia Commonwealth University. His work in these institutions has allowed him to collaborate with other experts in the field and further his research in immunotherapy.
Collaborations
Wang has collaborated with esteemed colleagues, including John R. Subjeck and Robert A. Henderson. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Xiang-Yang Wang's innovative work in immunotherapy and vaccine formulation showcases his dedication to advancing medical science. His contributions have the potential to significantly impact the treatment of cancer and infectious diseases, highlighting the importance of continued research and innovation in this field.